Present role of continuous subcutaneous insulin infusion by insulin pump in the treatment of diabetes mellitus;Aktueller stellenwert der kontinuierlichen subkutanen insulininfusion (CSII) mit insulinpumpen in der therapie des diabetes mellitus

Schweizerische Medizinische Wochenschrift

Volumn 130, Issue 48, 2000, Pages 1854-1861

  Pfutzner, A ^a   Berger, S ^a   Spinas, G ^a  

^a Institut fur Klinische Forschung und Entwicklung   (Germany)

Author keywords

CSII; Intensive insulin therapy; Pump therapy

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO;

ARTICLE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; INTRAVASCULAR CATHETER; KETOACIDOSIS;

BLOOD GLUCOSE; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 0034598061     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Intensive insulin treatment - Is it worth the effort?
3. Insulin injection treatment and its complications
4. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
5. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolscents with type 1 diabetes
6. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment: Multicenter Insulin Lispro Study Group
7. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes
8. Use of insulin lispro in continuous subcutaneous insulin infusion treatment - Results of a multicenter trial
9. Insulin lispro in CSII: Results of a double-blind crossover study
10. Continuous subcutaneous insulin infusion (CSII): A study comparing lispro to regular human insulin
11. Improvement of HbA(1c) and blood-glucose stability in IDDM patients treated with lispro insulin analog in external pumps
12. Blood glucose variability and well-being during CSII using insulin lispro and regular human insulin
13. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment
14. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas
15. Diabetic ketoacidosis charges relative to medical charges of adult patients with type 1 diabetes
16. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients
17. Catheter disconnection in type 1 diabetic patients treated with CSII: Comparison of insulin lispro and regular human insulin
18. Cessation of insulin infusion at night-time during CSII-therapy: Comparison of regular human insulin and insulin lispro
19. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM
20. Evaluation of an electrochemical sensor for measuring blood ketones
21. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: A pilot study
22. Erste klinische Erfahrungen mit einem praxistauglichen Glukosesensor